- Home
- ADTX vs IPDN Comparison
ADTX vs IPDN Comparison
Compare ADTX & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- IPDN
- Stock Information
- Founded
- ADTX 2017
- IPDN 2003
- Country
- ADTX United States
- IPDN United States
- Employees
- ADTX N/A
- IPDN N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- IPDN EDP Services
- Sector
- ADTX Health Care
- IPDN Technology
- Exchange
- ADTX Nasdaq
- IPDN Nasdaq
- Market Cap
- ADTX 5.3M
- IPDN 4.3M
- IPO Year
- ADTX 2020
- IPDN 2013
- Fundamental
- Price
- ADTX $2.30
- IPDN $1.41
- Analyst Decision
- ADTX
- IPDN
- Analyst Count
- ADTX 0
- IPDN 0
- Target Price
- ADTX N/A
- IPDN N/A
- AVG Volume (30 Days)
- ADTX 589.6K
- IPDN 413.6K
- Earning Date
- ADTX 05-19-2025
- IPDN 05-14-2025
- Dividend Yield
- ADTX N/A
- IPDN N/A
- EPS Growth
- ADTX N/A
- IPDN N/A
- EPS
- ADTX N/A
- IPDN N/A
- Revenue
- ADTX $133,985.00
- IPDN $6,730,605.00
- Revenue This Year
- ADTX $15,768.94
- IPDN N/A
- Revenue Next Year
- ADTX N/A
- IPDN N/A
- P/E Ratio
- ADTX N/A
- IPDN N/A
- Revenue Growth
- ADTX N/A
- IPDN N/A
- 52 Week Low
- ADTX $2.04
- IPDN $0.97
- 52 Week High
- ADTX $27,200.00
- IPDN $18.90
- Technical
- Relative Strength Index (RSI)
- ADTX 30.46
- IPDN 41.34
- Support Level
- ADTX $2.21
- IPDN $1.01
- Resistance Level
- ADTX $2.39
- IPDN $1.38
- Average True Range (ATR)
- ADTX 0.39
- IPDN 0.24
- MACD
- ADTX 0.49
- IPDN 0.06
- Stochastic Oscillator
- ADTX 11.11
- IPDN 42.72
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.